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Plasmodium falciparum (Pf ) and P. vivax (Pv) in-
fections cause significant morbidity and mortal-
ity worldwide (WHO Expert Committee on 
Malaria, 2000). The scaling up of control meth-
ods, including water and vector control, inter-
mittent preventive therapies (Kobbe et al., 2007), 
indoor residual spraying (Kolaczinski et al., 2007), 
and artemisinin combination therapies (Bhattarai 
et al., 2007), have reduced the incidence of Pf 
but not Pv malaria in many parts of the world 
(Nosten et al., 2000; Guerra et al., 2010; Oliveira-
Ferreira et al., 2010). Moreover, antimalarial 
drug resistance continues to emerge and malaria 
remains a major public health problem (Snow 
et al., 2005). A malaria vaccine would represent 
the most cost-effective strategy to tackle resis-
tance and protect humans from this disease. 
Consequently, numerous candidate vaccines are 
in development for Pf and Pv malaria (Pinzon-
Charry and Good, 2008) but an effective vac-
cine remains elusive. Importantly, Pf and Pv 
infections impair the generation of recall cellu-
lar (Walsh et al., 1995) and humoral responses 
(Williamson and Greenwood, 1978) affecting 
the generation of any type of vaccine immunity. 
Given the central role of DCs in directing pri-
mary and vaccine-induced immune responses 
(Banchereau et al., 2000), improved understanding 
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Malaria causes significant morbidity worldwide and a vaccine is urgently required. Plasmo­
dium infection causes considerable immune dysregulation, and elicitation of vaccine im­
munity remains challenging. Given the central role of dendritic cells (DCs) in initiating 
immunity, understanding their biology during malaria will improve vaccination outcomes. 
Circulating DCs are particularly important, as they shape immune responses in vivo and 
reflect the functional status of other subpopulations. We performed cross­sectional and 
longitudinal assessments of the frequency, phenotype, and function of circulating DC in  
67 Papuan adults during acute uncomplicated P. falciparum, P. vivax, and convalescent  
P. falciparum infections. We demonstrate that malaria patients display a significant reduc­
tion in circulating DC numbers and the concurrent accumulation of immature cells. Such 
alteration is associated with marked levels of spontaneous apoptosis and impairment in the 
ability of DC to mature, capture, and present antigens to T cells. Interestingly, sustained 
levels of plasma IL­10 were observed in patients with acute infection and were implicated 
in the induction of DC apoptosis. DC apoptosis was reversed upon IL­10 blockade, and DC 
function recovered when IL­10 levels returned to baseline by convalescence. Our data 
provide key information on the mechanisms behind DC suppression during malaria and will 
assist in developing strategies to better harness DC’s immunotherapeutic potential.
© 2013 Pinzon-Charry et al. This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six months after the publication date (see http://www.rupress.org/terms). After 
six months it is available under a Creative Commons License (Attribution–
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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(Jangpatarapongsa et al., 2008). We have also demonstrated nu-
merical blood DC reductions and increased apoptosis before 
patent parasitemia in healthy donors undergoing an experimen-
tal low-dose P. falciparum challenge (Woodberry et al., 2012). 
Further functional characterization, in contrast, has mainly been 
undertaken using in vitro or murine DC models (Urban et al., 
2001b; Perry et al., 2005; Elliott et al., 2007; Bettiol et al., 
2010). However, rodent DCs or DCs generated in vitro after 
prolonged culture with cytokines are unlikely to reflect the 
functional status of human DC populations circulating in vivo.
To address these questions, evaluate the role of different 
Plasmodium species on circulating DC, and determine the type 
and duration of DC impairment after antimalarial treatment, 
we performed cross-sectional and longitudinal assessments of 
all circulating DC subsets during uncomplicated Pf and Pv 
including convalescent Pf infection in 67 Papuan adults. Re-
sults were compared with a cohort of 17 malaria-exposed 
uninfected and asymptomatic Papuan adults. Given the low 
frequency of blood DC and restricted volumes that could be 
taken from patients, subcohorts were used for the various 
analyses. Our results demonstrate that the marked loss of func-
tional DC in the peripheral circulation of patients with Pf or 
Pv malaria is associated with significant levels of spontaneous 
of DC biology during acute malaria is paramount to improve 
vaccination outcomes.
Circulating DCs are particularly important as they replen-
ish tissue-residing DCs and shape immune responses in vivo 
(Banchereau et al., 2000). These cells can be identified as mono-
nuclear cells expressing MHC-II molecules (HLA-DR) but 
lacking common lineage markers (Savary et al., 1998). This 
blood DC compartment includes two different subsets discern-
ible into myeloid DC (mDC) or plasmacytoid DC (pDC) based 
on their reciprocal expression of CD11c or CD123 antigens 
(Robinson et al., 1999). Moreover, mDC can be further sub-
divided into three subtypes based on the respective expression 
of CD141, CD16, and CD1c antigens (Piccioli et al., 2007; 
Jongbloed et al., 2010). Despite their importance, most studies 
have only assessed blood DC’s numerical phenotype and few 
functional studies have been reported to date. Numerical char-
acterizations indicate that children with Pf display less acti-
vated mDC during acute uncomplicated infection (Urban et al., 
2001a) yet increased numbers of mDC during severe infec-
tion (Urban et al., 2006). Adults with Pf exhibit reduced pDC 
during acute uncomplicated, severe (Pichyangkul et al., 2004), 
or pregnancy malaria (Diallo et al., 2008). Similarly, adults 
infected with Pv display reduced mDC and pDC numbers 
Table 1. Study cohort
Subjects Age Sex Parasites/µl HRP2 Temperature
median (IQR) M/F median (IQR) median ng/ml (IQR) median °C (IQR)
Pf 42 23 (18–35) 27/15 5,655 (533–18,250) 107 (1.06–9.28)a 36.2 (36.1–37.9)
Pv 25 23 (19–31) 9/16 3,207 (1,020–8,067) n.d. 36.6 (36.3–37.1)
U 17 27 (20–24) 14/3 n.d. n.d. 36 (35.5–36.3)
a36 subjects. 10 of the 42 Pf patients were analyzed at days 7 and 28 after treatment. No peripheral parasitemia or HRP2 was detected on any Pf patient at days 7 or 28 after 
treatment. There were no significant differences between any of these groups. n.d., not detected. U, uninfected.
Figure 1. Altered blood DC subset  
distribution in malaria patients. (A) Periph-
eral blood DCs were identified as LinHLA-DR+ 
cells and analyzed for the expression of CD11c 
(y axis) and CD123 (x axis) by flow cytometry. 
The gating strategy for mDC, pDC, and a 
minor population of HLA-DR+ immature cells 
(DR+IC) is shown. Representative dot plots of 
the blood DC subset distribution in uninfected 
control and Pf or Pv patients are shown. Num-
bers indicate the percentage of cells within 
each gate. (B) Blood leukocyte counts includ-
ing lymphocyte, monocyte, neutrophil, mDC, 
pDC, and DR+IC were estimated in a cohort of 
45 patients with malaria (Pv, n = 19; Pf, n = 26) 
and compared with uninfected controls  
(U, n = 12). Absolute mDC, pDC, and DR+IC 
counts are expressed as 106/liter and all other 
counts are expressed as 109/liter. Box plots 
include means, standard deviations, and 
ranges. Significant differences compared  
with uninfected controls are indicated as  
***, P < 0.001.
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patients, but only Pf patients had detectable plasma histidine-
rich protein II (HRP2). No peripheral parasitemia or HRP2 
was detected in any Pf patient at days 7 or 28 after treatment.
Subset distribution of DC in patients with malaria
The blood DC compartment can be identified by flow cy-
tometry as LinHLA-DR+ cells (Thomas et al., 1993). This 
population includes two different subsets distinguished into 
myeloid DC (mDC) and plasmacytoid DC (pDC) lineages 
(Robinson et al., 1999). Because previous studies suggest dis-
similar changes in the frequency of these subsets in acute ma-
laria (Urban et al., 2006; Diallo et al., 2008; Jangpatarapongsa 
et al., 2008), we set out to carefully analyze the blood DC 
compartment in a cohort of 45 patients with acute Pf or Pv 
malaria (Fig. 1 A). Our data demonstrate a significant reduction 
in absolute counts of mDC (CD11c+) and pDC (CD123+) 
concurrent with the marked accumulation of HLA-DR+ im-
mature cells (DR+IC) in patients with acute malaria (Fig. 1 B). 
These immature cells lacked expression of CD11c or CD123 
markers yet expressed high levels of the HLA-DR antigen 
(Pinzon-Charry et al., 2005). Interestingly, this immature 
population represented only 16.8 ± 2.0% of the blood DC 
compartment in uninfected donors, while representing a much 
larger proportion in patients with Pv (38.6 ± 3.4%) or Pf 
(46.7 ± 1.8%) infection. The reduction in DC counts was, 
DC apoptosis. Impaired viability and numerical changes also 
correlate with functional impairment in the ability of DCs to 
up-regulate costimulatory and MHC-class II molecules as 
well as antigen uptake and presentation to CD4 T cells. In-
terestingly, elevated and sustained levels of plasma IL-10, as 
observed in patients with Pf or Pv, were implicated in the in-
duction of DC apoptosis. As such, DC apoptosis was reversed 
upon IL-10 blockade and DC function recovered completely 
after completion of antimalarial treatment and normalization 
of IL-10 levels by convalescence. Our data provide key infor-
mation on the mechanisms behind blood DC suppression 
during acute malaria and will assist in developing better strat-
egies to harness DC’s immunotherapeutic potential and im-
prove vaccination outcomes.
RESULTS
Study cohort
42 adult Papuans with acute uncomplicated Pf malaria, 25 adult 
Papuans with acute Pv malaria, and 17 uninfected malaria-
exposed Papuan adults were included in the study. 10 of the 
42 patients with Pf malaria were also assessed at days 7 and 28 
after antimalarial treatment. There was no significant differ-
ence in the age between groups although there were fewer 
female volunteers in the uninfected group (Table 1). Median 
peripheral parasitemia was similar in acute Pf and Pv malaria 
Figure 2. Altered mDC subset distribution 
in malaria patients. (A) mDCs (mDC, CD11c+ 
CD123+) were analyzed by flow cytometry for 
expression of CD141, CD1c, and CD16. DCs 
were gated as shown, and the populations 
were enumerated in the blood of 12 patients 
with malaria (Pv, n = 6; Pf, n = 6) and unin-
fected controls (U, n = 5). Data are expressed 
as cells/µl. Box plots include means, standard 
deviations, and ranges. Significant differences 
compared with uninfected controls are indi-
cated as *, P < 0.05. (B) In a cohort of Pv (n = 5)  
and uninfected (n = 5) individuals, lineage-
positive HLA-DR+ cells were analyzed for ex-
pression of CD11c and CD123 (DC), CD79a 
(B-cells), and CD11b (monocytes). Representa-
tive FACS plot from one Pv patient shown.
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undergoing apoptosis while eliminating cellular debris, gat-
ing was set as described in Fig. 3 A. Blood DCs were identi-
fied as LinHLA-DR+ cells and apoptosis was estimated using 
Annexin-V. As shown in Fig. 3 B, the minimal proportion 
of spontaneously apoptotic blood DC in uninfected donors 
was significantly increased in patients with Pv or Pf infection. 
Interestingly, apoptosis was mostly evident in DCs (mDC 
and pDC) as opposed to immature cells (DR+IC), partly ex-
plaining the large accumulation of DR+IC in patients with acute 
malaria (Fig. 3 C). Other antigen-presenting cells, such as B cells 
(CD19+) or monocytes (CD14+), displayed no significant apop-
tosis in patients with Pv (CD19+AnnexinV+: 6.4 ± 2.1%; and 
CD14+AnnexinV+: 7.3 ± 3.5%) or Pf (CD19+AnnexinV+: 
5.4 ± 3.1%; and CD14+AnnexinV+: 8.3 ± 2.3%) compared 
with uninfected controls (CD19+AnnexinV+: 5.7 ± 5.2%; and 
CD14+AnnexinV+: 8.3 ± 3.4%). These data suggest that in 
acute malaria, a process of specific DC suppression occurs 
whereby functional DCs are induced to undergo apoptosis 
while circulating in the blood.
Impaired phenotype and function of DC in patients with malaria
Next, we set out to determine if the reduced viability of blood 
DC was associated with phenotypic or functional abnormali-
ties. Because expression of MHC II and costimulatory molecules 
has been correlated to DC’s immunostimulatory capacity, first 
we evaluated the expression of CD83, CD86, and HLA-DR 
in patients with acute Pf or Pv malaria. As shown in Fig. 4 A, 
ex vivo expression (gray histograms) of CD83, CD86, and 
HLA-DR in blood DCs from Pv or Pf patients was compara-
ble to uninfected controls. However, upon overnight incu-
bation (black histograms), blood DCs from Pv or Pf patients 
showed markedly reduced ability to up-regulate expression 
of costimulatory and HLA-DR molecules (Fig. 4, A and B). 
Functional assessment also demonstrated significant DC im-
pairment in malaria patients. Here, blood DCs from Pv or Pf 
patients had a markedly reduced ability to take-up particulate 
however, not generalized to other leucocytes. As such, lym-
phocyte counts were only mildly (not significantly) reduced, 
monocyte counts were comparable, and neutrophil counts 
were only marginally increased (not significantly) compared 
with uninfected donors (Fig. 1 B).
Given that mDCs can be further subdivided into three 
subtypes based on their respective expression of CD141, CD16, 
and CD1c antigens (Piccioli et al., 2007; Jongbloed et al., 2010), 
numerical characterization of these mDC subsets was also un-
dertaken. Our data confirmed reduced counts of CD141+DC, 
CD1c+DC, and CD16+DC in patients with acute Pf and Pv 
malaria (Fig. 2 A). Although individual analyses revealed only 
significant reductions of CD1c+DC in Pf and CD16+DC in 
Pv, composite analyses of all malaria patients (Pv plus Pf ) con-
firmed significantly reduced counts (P < 0.05) for all mDC 
subtypes, suggesting a sample size effect.
To confirm that other DC subpopulations induced dur-
ing inflammatory settings were not excluded by confining our 
analyses to the LinHLA-DR+ population, characterization 
of the Lin+HLA-DR+ population was undertaken in five Pv 
patients (Fig. 2 B) compared with five uninfected controls. 
This confirmed the minimal proportion of DCs (<2%) and 
the rather large proportion of B cells (CD79a+ cells) and 
monocytes (CD11b+ cells) within this gate in malaria patients 
and uninfected donors (Pv: B cells, 59 ± 18%; monocytes, 30 ± 
5% vs. uninfected: B cells, 68 ± 10%; monocytes, 35 ± 8%). 
These results confirm that in patients with acute malaria, the 
marked reduction in LinHLA-DR+ cells in the peripheral 
circulation reflects significant reductions in all DC numbers 
(mDC subsets and pDC) and the concurrent accumulation of 
immature cells (DR+IC).
Spontaneous apoptosis of DC in patients with malaria
To determine whether reduced viability accounted for some 
of the changes observed in the DC compartment, we assessed 
spontaneous apoptosis in blood DC ex vivo. To include all cells 
Figure 3. Spontaneous apoptosis of blood DC in 
malaria patients. Blood DC from patients with ma-
laria (Pv, n = 19; Pf, n = 26) and uninfected matched 
controls (U, n = 12) were analyzed for apoptosis  
by flow cytometry. (A) Cells were gated on viable  
mononuclear cells (R1), which were further gated on  
7-AAD–negative cells (R2). Blood DCs were identified 
as LinHLA-DR+ cells (R3). Representative dot plots 
are shown. (B) Apoptosis in blood DC from uninfected 
donors (gray) and patients with malaria (black) was 
determined using Annexin-V binding assays. In all 
experiments, each patient was tested in parallel with 
at least one uninfected donor. Representative histo-
grams and summary of apoptosis data (mean ± SEM) 
are shown. (C) DC (mDC plus pDC) and DR+IC in unin-
fected donors and malaria patients were evaluated for 
apoptosis by Annexin-V staining. Numbers indicate 
the percentage of cells that are positive for Annexin-V. 
Statistically significant differences between uninfected 
controls and patients are shown. ***, P < 0.001.
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related to the inflammatory response during infection rather 
than to the parasite itself. To examine this hypothesis, first we 
evaluated levels of proinflammatory cytokines in plasma of all 
patients with acute malaria. We found significantly elevated 
levels of inflammatory cytokines, including IL-2, IL-4, IFN-, 
TNF, IL-6, and IL-10 in all patients with acute Pv or Pf in-
fection (Fig. 5 A). Interestingly, IL-2, IL-4, and IFN- levels 
corrected to baseline levels by day 7 (at which time parasites 
had cleared), whereas elevation of TNF, IL-6, and particularly 
IL-10 persisted beyond this point. Moreover, levels of plasma 
IL-10 (but not IL-6 or TNF) correlated with the extent of 
blood DC apoptosis (Fig. 5 B) yet no significant correlation 
was found between parasitemia or plasma HRP2 and either 
DC numbers or apoptosis (not depicted). This evidence sug-
gested a key role for IL-10 in blood DC apoptosis during 
acute infection.
Interestingly, sustained exposure of DC to high levels of 
IL-10 during their maturation has been associated with in-
duction of apoptosis (Chang et al., 2007). Therefore, we set 
out to directly evaluate the role of plasma IL-10 from malaria 
patients on DC survival in vitro. For this purpose, healthy DCs 
antigens (Fig. 4 C) and were poor stimulators of allogeneic 
CD4 T cell proliferation (Fig. 4 D) and Th1 cytokine secre-
tion (see Fig. 8 B). As shown in Fig. 4 C, impaired antigen 
uptake was evident in DC (mDC and pDC) as well as in im-
mature cells (DR+IC), although less markedly, explaining the 
overall dysfunction of all LinDR+ populations in patients 
with malaria. These data demonstrate that the impairment of 
blood DC in acute malaria affects key aspects of DC func-
tion, including maturation (up-regulation of costimulatory and 
MHC class II molecules), ability to capture antigen, and ade-
quate stimulation of allogeneic CD4 T cell proliferation and 
cytokine secretion.
Central role for IL­10 in induction  
of DC apoptosis during malaria
We also set out to assess possible mechanisms responsible for 
the marked levels of blood DC apoptosis in patients with ma-
laria. Given that no significant apoptosis was observed in un-
infected donors and a direct cytopathic effect of the parasite 
on DC has been excluded (Urban et al., 1999; Skorokhod et al., 
2004; Elliott et al., 2007), we hypothesized that apoptosis 
Figure 4. Impaired phenotype, antigen 
uptake, and stimulatory capacity in DC 
from malaria patients. (A) Expression of the 
costimulatory molecules CD83, CD86, and 
HLA-DR was analyzed on blood DC in a cohort 
of 45 patients with malaria (Pv, n = 19; Pf,  
n = 26) compared with uninfected controls  
(U, n = 12) directly ex vivo (gray histograms) 
or after overnight incubation (black histograms) 
without exogenous cytokines. Representative 
histograms are shown. (B) Summary of pheno-
typic analysis (mean ± SEM) for each antigen 
expressed as MFI (y axis) between cultured 
and fresh samples. (C) Blood DCs from unin-
fected donors (U, n = 12) or patients with 
malaria (Pv, n = 19; Pf, n = 26) were incubated 
with FITC-dextran at 4°C (gray) or 37°C (black), 
and uptake was measured by flow cytometry. 
Graph shows summary of antigen uptake 
data (mean ± SEM) presented as MFI (y axis) 
between test and control for all patients.  
(D) Blood DC from patients (Pf, n = 5; Pv, n = 5)  
and uninfected volunteers (U, n = 5) was 
tested against allogeneic CD4 T cells from a 
panel of healthy Australian donors (n = 5). CD4 
T cells and blood DCs were co-cultured at a 
30:1 T/DC ratio. Cells were harvested after  
96 h of culture and CD4 T cell proliferation 
estimated by CFSE dilution. Bars indicate the 
percentage of CFSEdim CD4 T cells for each 
stimulatory condition. In all experiments, each 
patient was tested in parallel with at least one 
uninfected donor. Results are representative of 
five separate experiments performed. Statisti-
cally significant differences compared with 
uninfected controls are indicated. *, P < 0.05; 
***, P < 0.001.
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were induced to mature with LPS and exposed to recombi-
nant human IL-10 or plasma samples from either uninfected 
donors containing low levels of IL-10 (mean 58.6 pg/ml, n = 3) 
or from patients with Pf (n = 3) or Pv (n = 3) containing high 
levels of IL-10 (Pf: mean 602.6 pg/ml; Pv: mean 353.8 pg/ml). 
First, we confirmed the proapoptotic effect of high and sus-
tained levels of rhIL-10 on healthy maturing blood DC 
(Fig. 6 A) as previously reported (Chang et al., 2007). More 
importantly, we found that exposure of healthy maturing DC 
(n = 5) to plasma from Pf or Pv patients resulted in a signifi-
cant proportion of DC apoptosis (Fig. 6 A). To further con-
firm the role of IL-10 in this process, specific IL-10 blocking 
was undertaken. As shown individually in Fig. 6 A, and sum-
marized in Fig. 6 B, blockade of rhIL-10 or infected plasma 
IL-10 prevented a comparably large proportion (mean rhIL-10: 
63% vs. Pf plasma: 53% vs. Pv plasma: 52%) of blood DC from 
undergoing apoptosis. These data confirmed the central role 
of IL-10 rather than other plasma cytokines in affecting DC 
survival and indicate that elevated levels of plasma IL-10 to 
the extent observed in patients with Pf or Pv can induce apop-
tosis in a significant proportion of blood DC.
Effect of antimalarial treatment on DC phenotype and function
Finally, to determine whether antimalarial treatment could 
reverse the impaired phenotype and viability of blood DC, 
we performed a longitudinal assessment in a cohort of 10 pa-
tients with Pf infection. In these patients, blood DCs were 
analyzed during acute malaria at day 0 and also at days 7 and 28 
after successful antimalarial drug treatment. We have demon-
strated elsewhere that artemisinin combination therapy drugs 
do not affect blood DC phenotype or function (Woodberry 
et al., 2012). Here, blood DCs were analyzed for their subset 
Figure 5. Profile of cytokines in plasma of patients with malaria. 
(A) The indicated plasma cytokines were measured by CBA assay in sam-
ples from Pf patients (n = 10) at days 0 (D0), 7 (D7), and 28 (D28) after 
antimalarial drug treatment and compared with patients with acute Pv  
(n = 19) or uninfected donors (U, n = 12). Summary of cytokine levels are 
presented as mean ± SEM for each cytokine. Significant differences com-
pared with uninfected controls are indicated as *, P < 0.05; **, P < 0.01; 
and ***, P < 0.001. (B) Correlation between the percentage of blood DC 
undergoing apoptosis (x axis) and cytokine levels for IL-6, TNF, and IL-10 
(y axis) in 45 patients with acute malaria (Pf, n = 26 and Pv, n = 19). 
Spearman’s Rank Test, R = 0.60, P < 0.0001 for IL-10; R = 0.14, P = 0.35 
for IL-6; and R = 0.07, P = 0.6 for TNF.
Figure 6. IL­10 induces apoptosis of maturing 
blood DC. (A) Blood DCs from healthy Australian do-
nors (n = 5) were induced to mature by 24 h incuba-
tion with LPS and subsequently exposed to either  
500 pg/ml of exogenous recombinant human IL-10 
(LPS + IL-10) or 50% (vol/vol) plasma samples from 
uninfected volunteers containing low levels of IL-10  
(n = 3, mean 58.6 pg/ml, U Plasma) or high levels of IL-10 
from Pf (n = 3; mean 602.6 pg/ml, Pf plasma) or Pv  
(n = 3; mean 353.8 pg/ml, Pv plasma) patients with or 
without anti–IL-10R antibodies. Representative histo-
grams from three donors are shown. Numbers indicate 
the percentage of apoptotic (Annexin-V+) blood DC in 
each culture. Results are representative of three sepa-
rate experiments. (B) Graph shows summary data of all 
donors. Statistically significant differences between 
samples exposed to blocking (anti–IL-10R) and non-
blocking (Isotype) antibodies as well as between U plasma 
and Pf or Pv plasma are indicated. Error bars show 
SEM. *, P < 0.05; ****, P < 0.0001.
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suggesting that malaria DCs were able to activate but not prop-
erly stimulate Th1 cell function in vitro. Reversal of such DC 
impairment, however, was evident in DCs collected by day 28 
after treatment (Figs. 7 and 8). Interestingly, plasma IL-10 
showed parallel kinetics to DC dysfunction with low IL-10 
levels comparable to uninfected donors attained by day 28 
after treatment (Fig. 5). Although these results suggest a pro-
tracted period of DC impairment, they confirm that full 
recovery of functional and competent blood DC is only achiev-
able after antimalarial drug treatment and normalization of 
IL-10 levels.
DISCUSSION
The aim of this study was to evaluate the blood DC compart-
ment in patients with Pf or Pv malaria to identify factors suit-
able for clinical implementation (i.e., antimalarial treatment) 
to improve their function. We focused on the blood DC com-
partment because this population directly reflects the natural 
biology of immune responses occurring in vivo. Therefore, de-
tailed cross-sectional and longitudinal assessments in 67 patients 
with acute uncomplicated Pf or Pv, as well as convalescent 
Pf malaria, were performed to demonstrate significant and 
protracted impairment in number, function, and viability of 
blood DC during acute malaria. More importantly, our results 
distribution, viability, phenotype, and ability to take up anti-
gen and stimulate allogeneic CD4 T cells. We found that pa-
tients with Pf infection exhibited a delayed correction in the 
numbers of mDC and pDC. In fact, mDC, pDC, and DR+IC 
counts only corrected to levels comparable to uninfected do-
nors by day 28 (Fig. 7, A and B). Similarly, the proportion of 
blood DC undergoing apoptosis remained significantly ele-
vated by day 7 and only returned to baseline levels equivalent 
to uninfected individuals by day 28 (Fig. 7, C and E). Antigen 
uptake also demonstrated a delayed improvement with efficient 
uptake comparable to uninfected donors only achieved by 
day 28 (Fig. 7, D and G). Up-regulation of the costimulatory 
phenotype followed a more rapid trend, with adequate ex-
pression of CD83 and CD86 achieved by day 7 yet efficient 
up-regulation in the expression of HLA-DR being delayed 
until day 28 (Fig. 7 F).
In keeping with these findings, characterization of the func-
tion and phenotype of T cells induced by stimulation with 
malaria DC revealed impaired allogeneic CD4 T cell prolif-
eration (Fig. 8 A) and inadequate induction of Th1 cytokines 
(Fig. 8 B). Interestingly, no significant differences in the ex-
pression of T cell activation markers CD25 (Pf: 48 ± 12% vs. 
U: 55 ± 12%), CD27 (Pf: 70 ± 8% vs. U: 73 ± 12%), or CD69 
(Pf: 7 ± 4% vs. U: 9 ± 5%) was evident in cultured T cells, 
Figure 7. Reversal of DC dysfunction after antimalarial treatment. (A and B) Blood DCs were analyzed during acute Pf malaria at day 0 (D0) and 
also at days 7 (D7) and 28 (D28) after antimalarial treatment in a cohort of 10 patients and compared with uninfected volunteers (U, n = 12). In all ex-
periments, each patient was tested in parallel with at least one uninfected volunteer. The blood DC compartment was analyzed for absolute counts of 
mDC, pDC, and DR+IC (106/liter; A) and blood DC subset distribution. (B) Representative dot plots of one uninfected control as well as one patient as-
sessed at days 0 (D0), 7 (D7), and 28 (D28) are shown. Values indicate percentage of cells within respective gates. (C) Summary of blood DC apoptosis 
data (mean ± SEM). (D) Summary of antigen uptake (FITC-Dextran) data assessed as the difference between uptake at 37°C (test) or 4°C (control) ex-
pressed as MFI (mean ± SEM). (E) Representative histograms of apoptosis from one patient at days 0 (D0), 7 (D7), and 28 (D28) compared with one  
uninfected control. Values indicate percentage of Annexin-V–positive cells. (F) Summary of phenotypic maturation estimated by up-regulation in expres-
sion of CD83, CD86, and HLA-DR expressed as MFI (mean ± SEM). (G) Representative histograms of antigen uptake from one patient at days 0 (D0),  
7 (D7), and 28 (D28) compared with one uninfected control. Gray histograms indicate uptake at 4°C (control) and black histograms represent uptake at 
37°C (test). Values indicate uptake as MFI between cultured and fresh samples. Statistically significant differences compared with uninfected volunteers 
are indicated as *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
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in the circulation (Pinzon-Charry et al., 2005). Other reports 
also indicate increased numbers of immature DCs during un-
complicated malaria in pregnancy (Aldebert et al., 2007; Diallo 
et al., 2008) and in children (Urban et al., 2001a). Although 
the reduction in functional DC and the accumulation of im-
mature cells had been proposed to contribute to immune dys-
function in malaria (Aldebert et al., 2007; Diallo et al., 2008), 
the mechanisms behind such changes and their functional 
consequences had not been investigated in the past. Recently, 
we demonstrated reduced counts and increased apoptosis 
of blood DC in healthy volunteers undergoing an experimen-
tal low-dose P. falciparum challenge (Woodberry et al., 2012). 
Here, we expand and complement our data by thoroughly 
characterizing blood DC phenotype, viability, and function 
in patients with clinical Pf and Pv malaria also establishing for 
the first time that IL-10 is implicated in the process.
Declining blood DC counts could be a direct consequence 
of increased migration to lymphoid tissues. In this regard, 
murine malaria models indicate rapid and vigorous DC mi-
gration to the spleen after infection (Rossi and Young, 2005). 
DC migration in human infection has been more difficult to 
assess as simultaneous data from blood and lymphoid organs 
are not available. However, in vitro models demonstrate that 
exposure of human DC to parasitized red cells increase their 
expression of chemokine receptors CCR7 and CXCR4 
(Pichyangkul et al., 2004; Giusti et al., 2011), suggesting en-
hanced lymphoid organ migration during infection. Prelimi-
nary data from our laboratory also support this notion and show 
demonstrate that full recovery of functional and competent 
blood DC is achievable only after adequate antimalarial drug 
treatment and normalization of IL-10 levels in patients with 
acute malaria.
Although previous studies have reported changes of blood 
DC in people with malaria, results have been contradictory 
and limited functional data are available. Children with severe 
Pf have been reported to exhibit increased numbers of mDC 
(Urban et al., 2006), whereas adults with Pf have reduced pDC 
during uncomplicated and severe disease (Pichyangkul et al., 
2004). Adults with Pv also appear to have reduced mDC and 
pDC (Jangpatarapongsa et al., 2008; Gonçalves et al., 2010). 
Our data, examining adults with acute malaria demonstrate 
the significant and comparable reduction in mDC, including 
all mDC subsets (CD141+DC, CD1c+DC, and CD16+DC) 
as well as pDC counts in patients with Pf or Pv infection. 
An immature population (DR+IC) distinct from the myeloid 
(mDC) and plasmacytoid (pDC) subtypes also emerged as a 
significant proportion of the DC compartment. These imma-
ture cells are known to express high levels of HLA-DR (100%) 
and display variable expression of other DC markers like CD2, 
DC-SIGN, BDCA-4, CD4, or CD1c (3–20%). Similarly, a 
variable proportion of DR+ICs express progenitor antigens 
like CD7, CD10, CD13, or CD33 (3–20%), myeloid anti-
gens like MPO or CD15 (1–5%), lymphoid markers like 
CD79a (15–20%), or integrins like CD11b, CD62L, CD41, or 
CD61 (5–30%), altogether suggesting that multiple small sub-
populations of progenitors, as well as immature DCs, coexist 
Figure 8. Recovery of DC allostimulatory capacity 
after antimalarial treatment. (A) Naive allogeneic 
CD4 T cells purified from a panel of healthy Austra-
lian donors (n = 5) were co-cultured with blood DC 
from malaria patients at day 0, 7, or 28 (n = 8) or 
uninfected controls at a 30:1 T/DC ratio (n = 12). Cells 
were harvested after 96 h of culture and CD4 T cell 
proliferation estimated by CFSE dilution (x axis). Rep-
resentative histograms are shown with numbers indi-
cating the percentage of CFSEdim CD4 T cells for each 
stimulatory condition. The representative pairs giving 
maximal responses for three different T cell donors 
are shown. In all experiments, each patient was tested 
in parallel with at least one uninfected volunteer. 
(B) Supernatants from cultures in A were harvested 
after 72 h and levels of IL-2, TNF, IFN-, IL-6, IL-4, 
and IL-10 estimated using CBA assay by FACS. Box 
plots include means, standard deviations, and ranges. 
Significant differences compared with uninfected 
controls are indicated as *, P < 0.05. Results are rep-
resentative of five separate experiments performed.
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exposure of DC to IL-10 can suppress the induction of anti-
apoptotic genes like bcl-2, bcl-x, and bfl-1 at a time of increased 
sensitivity to viability signals, i.e., during DC maturation (Chang 
et al., 2007). Additionally, exocrine IL-10 can drive secretion 
of autocrine IL-10 by DC and other cell types further im-
pacting on cell survival (Corinti et al., 2001). In human ma-
laria for example, in vitro–derived DCs exposed to infected 
erythrocytes fail to secrete IL-12 yet produce increasing lev-
els of IL-10 (Urban et al., 1999). Similarly, in rodent malaria, 
DCs progressively increase their ability to produce IL-10 and 
induce an IL-10–dominated T cell response (Perry et al., 2005). 
Therefore, while controlling immunopathology, the scale of 
IL-10 exposure throughout the maturation process appears to 
determine the lifespan of blood DC via mechanisms involv-
ing cytokine regulation and antiapoptotic gene modulation.
Although apoptosis and high levels of IL-10 appeared 
central to DC impairment in the present study, other mecha-
nisms have also been proposed. Earlier studies using in vitro–
derived DC indicate that Plasmodium can compromise DC 
via a mechanism involving direct contact through Pf EMP1 
(Urban et al., 2001b). However, more recent evidence using 
a similar in vitro approach suggests that modulation is inde-
pendent of parasite contact and rather depends on parasite dose 
(Elliott et al., 2007). Because Pv-infected red cells do not ex-
press pfEMP1 and are minimally cytoadherent, our finding of 
comparable DC impairment with either parasite would sup-
port the contact-independent nature of DC modulation. Other 
reports also implicate hemozoin in the modulation of DC 
through TLR-dependent binding (Coban et al., 2005; Parroche 
et al., 2007) and suggest that induction of TLR tolerance is 
central to DC dysregulation (Perry et al., 2005). In our study, 
sample limitation precluded direct assessment of blood DC–
parasite interactions ex vivo. However, the observations that 
DC apoptosis and dysfunction persisted beyond parasite clear-
ance (day 7), was in part IL-10 dependent, and normalized by 
day 28 upon resolution of the cytokine response suggested that 
DC impairment during clinical disease was primarily related 
to the immune response against the parasite rather than to 
the parasite itself. The lack of correlation between baseline 
parasitemia or plasma HRP2 and either DC numbers or apop-
tosis also indicated that by the time of presentation with cli-
nical malaria, DC impairment was cytokine driven rather than 
parasite driven.
Whereas an alteration in the numerical and maturational 
phenotype of blood DC in acute malaria had been previously 
described (Jangpatarapongsa et al., 2008; Gonçalves et al., 2010), 
there had only been few reports on the function of blood DC 
in patients with clinical malaria (Arama et al., 2011) and no 
longitudinal studies in clinical disease had been described to 
date. Our cross-sectional assessment in 67 Papuan adults with 
acute malaria allowed us to demonstrate that the marked 
changes in blood DC viability were associated with signifi-
cant impairment in all aspects of DC function (maturation, 
antigen uptake, and presentation) in patients with either type 
of parasite. In fact, we show that blood DC from Pf and Pv 
patients display impaired ability to up-regulate costimulatory 
increased expression of CCR7, CXCR4, and CCR5 in blood 
DC of patients with Pf or Pv malaria (unpublished data). Al-
though increased migration to lymphoid organs is likely oc-
curring, its effect on peripheral counts is unclear and a definitive 
answer will only arise from the simultaneous assessment of DC 
in blood and lymphoid tissues. Myeloid suppression or im-
paired production of DC progenitors could also be proposed 
to explain declining blood DC numbers in human malaria. 
However, our data on the accumulation of immature cells and 
similar reports of increased immature DC during maternal 
human infection (Aldebert et al., 2007; Diallo et al., 2008) or 
CD34+ DC progenitors in blood of children with malaria 
(Urban et al., 2001a) suggest that myeloid suppression is un-
likely to be of significance. Finally, impaired viability of blood 
DC could contribute to declining counts if a significant pro-
portion of cells are programmed to die while in the circula-
tion. Our results not only confirm the latter hypothesis but 
suggest that the cytokine milieu occurring in vivo is impact-
ing vigorously on the longevity of all blood DC subpopula-
tions during infection.
The physiological significance of this finding is three-
pronged. First, circulating DCs are essential for adequate im-
munity as they continually replenish the pool of tissue-residing 
DCs. In fact, most circulating DCs are en route from the bone 
marrow to peripheral and lymphoid tissues or from nonlym-
phoid tissues to the regional lymph nodes and spleen (de la 
Rosa et al., 2003). Given that apoptotic cells are rapidly cleared 
by the reticulo-endothelial system, increased turnover rate of 
blood DC is likely occurring in these patients. As infection 
progresses, continual efforts to replace the pool of blood DC 
from bone marrow imposes pressure on hematopoietic capacity, 
resulting in the paucity of functional DC (Urban et al., 2001a; 
Aldebert et al., 2007; Diallo et al., 2008; Jangpatarapongsa 
et al., 2008) and the concurrent accumulation of immature cells 
in the circulation (Aldebert et al., 2007; Diallo et al., 2008). 
Second, apoptotic DCs are ineffective at inducing immunity 
(Kitajima et al., 1996), and this can contribute to systemic im-
mune dysregulation and parasite evasion. Third, apoptosis can 
relate to the immune response against the parasite rather than 
a direct cytopathic effect of the parasite, and hence it may be 
amenable to modification through normalization of the sup-
pressive cytokine environment in which DCs are engaged.
In this regard, cytokines that regulate the inflammatory re-
sponse, and particularly IL-10, have been suggested to affect 
blood DC during acute malaria (Urban et al., 2006; Diallo et al., 
2008). Maturing DCs undergo apoptosis after exposure to high 
levels of IL-10 (Chang et al., 2007), and a correlation between 
high IL-10 and reduced DC counts has been suggested for 
human Pf (Urban et al., 2006; Diallo et al., 2008) and Pv in-
fections (Jangpatarapongsa et al., 2008; Gonçalves et al., 2010). 
Here, we demonstrate for the first time a direct causal rela-
tionship between increased levels of plasma IL-10 and blood 
DC apoptosis in patients with clinical Pf or Pv infections. In 
malaria, IL-10 is an important cytokine and immune modu-
lator that strikes a balance between immune protection and 
immunopathology (Couper et al., 2008). However, sustained 
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All antibodies were used as FITC, PE, biotin, APC, or PE-Cy5 conju-
gated. Complete media included RPMI 1640 supplemented with 10% FCS, 
100 U/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine, 25 mM 
Hepes, and nonessential amino acids (Gibco). 10 ng/ml LPS and 1 mg/ml 
FITC-Dextran were purchased from Sigma-Aldrich.
Flow cytometry, antigen uptake, and mixed leukocyte reaction. 
PBMCs were stained with the lineage mixture (CD3, CD14, CD19, CD20, 
CD56, and CD34) and HLA-DR. Flow cytometry (FACS) was used to 
evaluate DC numbers, phenotype, antigen uptake, and function. Blood DCs 
were defined as LinHLA-DR+ cells. Blood DC subsets were identified 
using CD11c (mDC) and CD123 (pDC) antibodies. mDC subsets were fur-
ther characterized using CD141, CD1c, and CD16 antigens. Antigen uptake 
was assessed after cells were incubated (107 cells/ml) for 60 min with FITC-
Dextran at either 37°C (test) or 4°C (control). Antigen uptake was calcu-
lated as the difference in mean fluorescence intensity (MFI) between the 
test and control. To assess allostimulatory capacity, PBMCs from patients or 
uninfected volunteers were individually tested against naive allogeneic CD4 
T cells obtained from buffy coats from healthy Australian volunteers (n = 5, 
Australian Red Cross). Naive allogeneic CD4 T cells (>95% CD4) were pu-
rified by negative immunoselection using the naive CD4 T cell isolation kit 
(Miltenyi Biotec) and labeled using the vibrant CFDA-SE Cell Tracer Kit 
(Molecular Probes). CD4 T cells were adjusted at 105/well and cultured 
with DCs from malaria patients or uninfected controls at a 30:1 T/DC ratio 
in PBMC cultures. In all cases, DC numbers were adjusted based on absolute 
counts estimated by FACS before culture. Cells were harvested after 96 h 
of culture and CD4 T cell proliferation estimated by CFSE dilution using 
MODFIT proliferation software (Verifit Software). Similar results were found 
for all T/DC ratios. In all experiments, cells were analyzed within 1 h of 
staining and 5–10 × 105 events were collected within the mononuclear cell 
gate. Absolute DC counts were calculated from the number of PBMCs/liter 
of blood as determined by the automated cell counter multiplied by the per-
centage of DCs determined by FACS. Lymphocyte, monocyte, and neutrophil 
counts were determined by automated cell counter. Serum and supernatant 
cytokines were measured using the cytometric bead array (CBA) for human 
Th1/Th2 cytokine kit (BD). Data were acquired on a FACSCalibur equipped 
with CellQuestPro and CBA software (BD) according to the manufac-
turer’s instructions.
Apoptosis and IL-10 assay. To determine the proportion of apoptotic 
cells, Annexin-V binding assays were performed according to the manufac-
turer’s instructions (Annexin-V kit; BD). Briefly, PBMCs were adjusted to 
106 cells/ml and stained with lineage markers and HLA-DR as above. Cells 
were washed and resuspended in binding buffer before incubating with 
Annexin-V and 7-AAD. 7-AAD was added as a viability indicator except 
when co-labeling for CD11c plus CD123 expression. In all experiments, DC 
apoptosis was analyzed by FACS within 1 h of staining. The proapoptotic ef-
fects of IL-10 on DC were tested as previously described (Chang et al., 2007). 
In brief, PBMC cultures (107 cells/ml) from healthy adult Australian volun-
teers (n = 5) were incubated in complete medium with 10 ng/ml LPS and 
either 500 pg/ml rhIL-10 (R&D Systems) or 50% (vol/vol) plasma from pa-
tients with Pf (n = 3; mean IL-10 concentration 602.6 pg/ml) or Pv (n = 3; 
mean IL-10 concentration 353.8 pg/ml) for 24 h. Blood DC apoptosis was 
estimated by Annexin-V staining. Cultures incubated with LPS alone or serum 
from uninfected volunteers (n = 3; mean IL-10 concentration 58.6 pg/ml) 
served as controls. To neutralize IL-10, 5 µg/ml anti–IL-10R1 mAb or the 
respective IgG1 isotype control (R&D Systems) was added to cultures as 
indicated. Doses and incubation times were optimized in preliminary experi-
ments. In all experiments, 5–10 × 105 events were collected within the 
mononuclear cell gate. Data were acquired on a FACSCalibur and analyzed 
using CellQuest 3.1 or Summit (Cytomation) software.
Statistical analysis. All statistical analyses used Prism 5 (GraphPad Software 
Inc.). Comparisons of samples to establish statistical significance were de-
termined by the two tailed Student’s t test or one way analysis of variance 
and MHC class II molecules as well reduced antigen uptake 
and ability to stimulate CD4 T cell proliferation and cytokine 
secretion. Moreover, upon longitudinal follow up, we dem-
onstrate that parasite clearance and normalization of the cyto-
kine milieu after antimalarial treatment facilitate recovery of 
fully competent blood DC in patients with malaria.
Therefore, our findings point out that impairment of blood 
DC number and function, as well as induction of apoptosis, 
is not species-specific and occurs with the two Plasmodium 
species causing the majority of global malaria. Consequently, 
our results have significant implications not only for under-
standing immune dysfunction during malaria but also for the 
development of effective interventions to improve vaccina-
tion outcomes against this disease. In view of the remark-
able diversity of immunosuppressive pathways in malaria, any 
clinical response achieved by vaccination is already considered 
an achievement. However, to improve responses to any of 
the current subunit or whole parasite vaccine formulations 
(Pinzon-Charry and Good, 2008), vaccines will need to be 
combined with other strategies that can offset the suppressive 
environment in which DCs are primed. Given the protracted 
nature of the DC dysfunction described here in patients with 
acute infection and the observation that parasite clearance 
and normalization of the cytokine milieu after antimalarial 
treatment facilitate DC recovery, combination strategies will 
likely be required. Based on the evidence presented here, 
we propose that vaccination in the context of iterative pre-
ventive therapies, pre-vaccination antimalarial treatment, im-
munization during nontransmission season, or the use of 
approaches which vigorously stimulate DC and cellular im-
munity (Pinzon-Charry et al., 2010) should be considered to 
improve vaccination outcomes for malaria.
MATERIALS AND METHODS
Study subjects and samples. 84 highland Papuans were recruited in Timika, 
a lowland region of Papua, Indonesia, with perennial unstable malaria trans-
mission of both Pf and Pv (Karyana et al., 2008). Subjects were enrolled in 
trials of chloroquine and sulphadoxine-pyrimethamine or artemisinin com-
bination therapy after providing informed consent (Ratcliff et al., 2007a,b). 
Individuals with acute uncomplicated malaria—as defined by acute onset of 
fever within 48 h of enrolment—with no alternative cause identified and 
parasitemia by microscopically identified Pf (n = 42) or Pv (n = 25) were in-
cluded in the study. No patients with mixed infection were included. For all 
patients, venous blood was collected at the time of presentation. Addition-
ally, in 10 Pf patients with clinical and parasitological cure, venous blood was 
also collected at 7 and 28 d after successful antimalarial drug treatment with 
chloroquine plus sulfoadioxine-pyrimethamine or artemisinin combination 
therapy (ACT). Malaria-exposed uninfected subjects (n = 17) served as 
controls; these were resident in the Timika district for at least 2 yr and had 
no fever or symptoms of malaria within the preceding 2 wk as previously 
described (Randall et al., 2010). The studies were approved by the Ethics 
Committees of the National Institute of Health Research and Develop-
ment, Ministry of Health, Jakarta, Indonesia; the Menzies School of Health 
Research, Darwin, Australia; and the Queensland Institute of Medical Re-
search, Brisbane, Australia.
Antibodies and reagents. The following mAbs were used in this study: 
CD3, CD14, CD19, CD20, CD56, CD34, HLA-DR, CD86, CD25, CD27, 
CD69, CD79a, and CD11b and IgG1, IgG2a, and IgG2b isotype controls (BD); 
and HLA-DR, CD83, CD19, and IgG1 isotype control (Beckman Coulter). 
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